Literature DB >> 27111029

Management of gastroparesis-associated malnutrition.

Shishira Bharadwaj1, Krishna Meka2, Parul Tandon2, Abdullah Rathur2, John M Rivas3, Hiren Vallabh1, Andrea Jevenn1, John Guirguis1, Imran Sunesara4, Amy Nischnick1, Andrew Ukleja3.   

Abstract

Gastroparesis (GP) is a chronic debilitating dysmotility characterized by unrelenting nausea, vomiting, bloating, early satiety, postprandial fullness and abdominal pain. Patients with GP experience other associated conditions, including gastroesophageal reflux disease, gastric bezoars and small bowel bacterial overgrowth. Furthermore, GP is associated with poor quality of life, increased emergency room visits, hospitalizations and subsequent increased healthcare costs. Currently, the managements of GP consist of glycemic control, antiemetics, prokinetics and the use of gastric electrical stimulation. However, most GP patients are at risk for significant nutritional abnormalities. As such, it is essential to screen and diagnose malnutrition in these patients. Poor oral intake in such patients could be supplemented by enteral tube feeding. Parenteral nutrition, although a last resort, is associated with a number of complications and should be used only for the short term. In summary, a systematic approach including initial nutritional screening, diet recommendations, medical therapy, nutritional re-evaluation and enteral and parental nutrition should be considered in complex GP patients.
© 2016 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  enteral nutrition; gastroparesis; malnutrition; parenteral nutrition

Mesh:

Substances:

Year:  2016        PMID: 27111029     DOI: 10.1111/1751-2980.12344

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  5 in total

1.  Management of Gastroparesis.

Authors:  Ting Zheng; Michael Camilleri
Journal:  Gastroenterol Hepatol (N Y)       Date:  2021-11

2.  Early-life malnutrition causes gastrointestinal dysmotility that is sexually dimorphic.

Authors:  Krishnakant G Soni; Peace N Dike; Ji Ho Suh; Tripti Halder; Price T Edwards; Jaime P P Foong; Margaret E Conner; Geoffrey A Preidis
Journal:  Neurogastroenterol Motil       Date:  2020-07-06       Impact factor: 3.598

3.  The Combination Therapy of Dissolution Using Carbonated Liquid and Endoscopic Procedure for Bezoars: Pragmatical and Clinical Review.

Authors:  Kohei Ogawa; Kenya Kamimura; Ken-Ichi Mizuno; Yoko Shinagawa; Yuji Kobayashi; Hiroyuki Abe; Yukari Watanabe; Shunsaku Takahashi; Kazunao Hayashi; Junji Yokoyama; Manabu Takeuchi; Masaaki Kobayashi; Satoshi Yamagiwa; Yuichi Sato; Shuji Terai
Journal:  Gastroenterol Res Pract       Date:  2016-08-23       Impact factor: 2.260

4.  Non-Clinical Safety Pharmacology Evaluations of Trazpiroben (TAK-906), a Novel Dopamine D2/D3 Selective Receptor Antagonist for the Management of Gastroparesis.

Authors:  Laura Kreckler; Mark Osinski; Scott Williams; Roger Whiting
Journal:  J Exp Pharmacol       Date:  2022-02-09

5.  United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on gastroparesis.

Authors:  Jolien Schol; Lucas Wauters; Ram Dickman; Vasile Drug; Agata Mulak; Jordi Serra; Paul Enck; Jan Tack
Journal:  United European Gastroenterol J       Date:  2021-04       Impact factor: 4.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.